metabolic associated steatohepatitismoderate to advanced fibrosis scarringliver diseasesemaglutideUS Food and Drug Administration
…reatment of patients with a severe form of liver disease called metabolic associated steatohepatitis (MASH) and moderate to advanced fibrosis scarring.1…